Latest publications Tumour Marker Group

Syversen SW, Bolstad N, Haavardsholm EA (2021)
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply
JAMA, 326 (11), 1069-1070
DOI 10.1001/jama.2021.11480, PubMed 34546304

Dorn-Rasmussen M, Buhl S, Brynskov J, Bay JT, Bolstad N, Klausen TW, Warren DJ, Ainsworth MA, Steenholdt C (2021)
Drug Levels Associated with Optimal Discrimination Between Remission and Non-Remission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease
Ther Drug Monit (in press)
DOI 10.1097/FTD.0000000000000913, PubMed 34387220

Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2021)
Thyroid hypofunction in aging testicular cancer survivors
Acta Oncol, 60 (11), 1452-1458
DOI 10.1080/0284186X.2021.1958004, PubMed 34351829



More publications

 
Page visits: 1083